CX11 is named as a drug or biological intervention in 4 clinical trials in our USA and China trial registers, 2 of which are recruiting. Lead sponsors include Corxel Pharmaceuticals (2) and Vincentage Pharma Co., Ltd (2). Registered phases: Phase 1 and Phase 2. Conditions studied include Obesity & Overweight; Type II Diabetes Mellitus; Type 2 Diabetes.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07340320 | A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus (ClinicalTrials.gov ↗) Type II Diabetes Mellitus |
Phase 2 | Recruiting |
| NCT07652047 | A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets Obesity & Overweight |
Phase 1 | Recruiting |
| NCT07360275 | A Study of VCT220 in Participants With Hypertension and Obesity or Overweight (ClinicalTrials.gov ↗) Hypertension |
Phase 2 | Active, closed |
| NCT07349381 | A Food-Effect Study of CX11 in Healthy Participants (ClinicalTrials.gov ↗) Obesity & Overweight, Type 2 Diabetes |
Phase 1 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Obesity & Overweight | 2 |
| Type II Diabetes Mellitus | 1 |
| Type 2 Diabetes | 1 |
| Hypertension | 1 |
| Lead sponsor | Trials |
|---|---|
| Corxel Pharmaceuticals | 2 |
| Vincentage Pharma Co., Ltd | 2 |
| Register | CX11 trials |
|---|---|
| Clinical trials in USA | 2 |
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how CX11 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists CX11 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.